←Back to Expert Scholars
Translational Medicine / 转化医学Melanoma Research Milestones
Antoni Ribas
MD, PhD
🏢University of California Los Angeles🌐USA
Professor of Medicine, Surgery, and Molecular and Medical Pharmacology
150
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Antoni Ribas led development of pembrolizumab in melanoma and has pioneered mechanistic work on immunotherapy resistance and adoptive cell therapy. His work has shaped the modern era of melanoma treatment. He is a past president of AACR.
Share:
🧪Research Fields 研究领域
melanoma
immunotherapy
pembrolizumab
adoptive cell therapy
resistance
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Antoni Ribas 的研究动态
Follow Antoni Ribas's research updates
留下邮箱，当我们发布与 Antoni Ribas（University of California Los Angeles）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment